Companies Oscar Health, Inc.
Oscar Health (OSCR): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Oscar Health, Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers1st pct.Of 14 peer CEOs
CEO pay, last three years
- $44,538,114FY2023
- $915,000FY2024
- $1,149,308FY2025
CEO total pay was $1,149,308 in fiscal 2025, up from $915,000 in fiscal 2024.
FY2025: salary $619,178 · bonus $0 · stock awards $0 · option awards $0
Executives and directors
Adam McAnaney · General CounselR. Scott Blackley · CFOJanet Liang · EVPMario Schlosser · PresidentMark Bertolini · CEODavid Plouffe · Independent DirectorElbert O. Robinson, Jr · Former director (through FY2025)Jeffery H. Boyd · Independent DirectorJoshua Kushner · DirectorLaura Lang · Independent DirectorSiddhartha Sankaran · Independent DirectorVanessa A. Wittman · Independent DirectorWilliam Gassen III · Independent Director
Frequently asked questions
Who was the highest-paid executive at Oscar Health, Inc. in fiscal 2025?
As disclosed, Janet Liang (President of Oscar Insurance) was the highest-paid executive at Oscar Health, Inc. in fiscal 2025, with total compensation of $10,400,673.
How does Oscar Health, Inc.'s chief executive pay compare to its disclosed peer group?
As disclosed, Mark Bertolini's total compensation ranked at the 1st percentile of Oscar Health, Inc.'s disclosed peer group.
What is Oscar Health, Inc.'s CEO-to-median employee pay ratio?
As disclosed, Oscar Health, Inc.'s CEO-to-median employee pay ratio was 10.4:1.
How did shareholders vote on Oscar Health, Inc.'s executive compensation?
As disclosed, 98.86% of shareholders supported Oscar Health, Inc.'s executive compensation in the latest say-on-pay vote.
How much does Oscar Health, Inc. spend in total on board compensation for fiscal 2025?
As disclosed, Oscar Health, Inc. reported total board compensation of $1,900,972 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Janet Liang | $512,500 | $2,800,000 | $4,943,054 | $1,499,992 | $465,222 | $0 | $179,905 | $10,400,673 |
| President of Oscar Insurance | ||||||||
| Mario Schlosser | 600,000 | 0 | 6,139,667 | 0 | 546,000 | 0 | 28,905 | 7,314,572 |
| Co-Founder, President of Technology & Chief Technology Officer | ||||||||
| Adam McAnaney | 512,500 | 335,000 | 4,072,568 | 1,899,991 | 279,133 | 0 | 29,905 | 7,129,097 |
| Chief Legal Officer | ||||||||
| Scott Blackley | 600,000 | 0 | 3,686,103 | 0 | 436,800 | 0 | 29,905 | 4,752,808 |
| Chief Financial Officer | ||||||||
| Mark Bertolini | 619,178 | 0 | 0 | 0 | 169,036 | 0 | 361,094 | 1,149,308 |
| Chief Executive Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Janet Liang | $10,400,673 | — | — | — |
| Mario Schlosser | 7,314,572 | 10,847,822 | 854,000 | ↓ −3,533,250 |
| Adam McAnaney | 7,129,097 | — | — | — |
| Scott Blackley | 4,752,808 | 5,446,439 | — | ↓ −693,631 |
| Mark Bertolini | 1,149,308 | 915,000 | 44,538,114 | ↑ +234,308 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company's compensation philosophy is to pay for performance by delivering the majority of compensation in the form of at-risk, variable pay directly tied to clearly articulated financial, strategic, and operational performance measures. The program aims to maximize stockholder value by aligning executive interests with long-term stockholder interests through equity compensation and relative TSR assessment, while also attracting and retaining top talent in a competitive marketplace.
| CEO STI target (% of salary) | 30% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Adam McAnaney | PSU | 2025-03-05 | 23,028 | 61,409 | — | 171,945 | $1,190,721 |
| Adam McAnaney | RSU | 2025-02-24 | — | — | 123,376 | — | 1,883,952 |
| Mario Schlosser | PSU | 2025-03-05 | 64,601 | 172,269 | — | 482,353 | 3,340,296 |
| Mario Schlosser | RSU | 2025-03-05 | — | — | 172,269 | — | 2,799,371 |
| Janet Liang | OPTION | 2025-02-24 | — | — | 147,637 | — | 1,499,992 |
| Janet Liang | RSU | 2025-02-24 | — | — | 97,402 | — | 1,487,329 |
| Janet Liang | RSU | 2025-03-05 | — | — | 96,962 | — | 1,575,633 |
| Adam McAnaney | RSU | 2025-03-05 | — | — | 61,409 | — | 997,896 |
| Adam McAnaney | OPTION | 2025-02-24 | — | — | 185,004 | — | 1,899,991 |
| Janet Liang | PSU | 2025-03-05 | 36,361 | 96,962 | — | 271,494 | 1,880,093 |
| Scott Blackley | PSU | 2025-03-05 | 38,785 | 103,426 | — | 289,593 | 2,005,430 |
| Scott Blackley | RSU | 2025-03-05 | — | — | 103,426 | — | 1,680,673 |
| Scott Blackley | RSU | 2025-03-05 | — | — | 103,426 | — | 1,680,673 |
| Scott Blackley | PSU | 2025-03-05 | 38,785 | 103,426 | — | 289,593 | 2,005,430 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Adam McAnaney | $2,881,848 | $1,190,721 | $1,899,991 | 19.9% |
| Mario Schlosser | 2,799,371 | 3,340,296 | 0 | 54.4% |
| Janet Liang | 3,062,962 | 1,880,093 | 1,499,992 | 29.2% |
| Scott Blackley | 3,361,346 | 4,010,860 | 0 | 54.4% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Scott Blackley | RSU | 43,263 | — | $621,689 |
| Adam McAnaney | RSU | 46,057 | — | 661,839 |
| Adam McAnaney | PSU | 61,409 | — | 882,447 |
| Mario Schlosser | RSU | 72,059 | — | 1,035,488 |
| Janet Liang | RSU | 72,722 | — | 1,045,015 |
| Scott Blackley | RSU | 77,570 | — | 1,114,681 |
| Janet Liang | RSU | 79,139 | — | 1,137,227 |
| Janet Liang | PSU | 96,962 | — | 1,393,344 |
| Scott Blackley | PSU | 103,226 | — | 1,483,358 |
| Scott Blackley | PSU | 103,426 | — | 1,486,232 |
| Scott Blackley | Option | 110,981 | 6.62 | — |
| Janet Liang | Option | 119,955 | 15.27 | — |
| Adam McAnaney | RSU | 123,376 | — | 1,772,913 |
| Mario Schlosser | RSU | 129,202 | — | 1,856,633 |
| Mario Schlosser | RSU | 129,705 | — | 1,863,861 |
| Mario Schlosser | PSU | 171,935 | — | 2,470,706 |
| Mario Schlosser | PSU | 172,269 | — | 2,475,506 |
| Adam McAnaney | Option | 185,004 | 15.27 | — |
| Scott Blackley | RSU | 187,889 | — | 2,699,965 |
| Mark Bertolini | RSU | 955,555 | — | 13,731,325 |
| Mark Bertolini | PSU | 1,720,000 | — | 24,716,400 |
| Mark Bertolini | RSU | 5,733,334 | — | 82,388,010 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Jeffery H. BoydIndependent · Board Chair · Nominating and Corporate Governance (Chair) · Audit (ex-officio, non-voting) · Talent and Compensation (ex-officio, non-voting) · Not standing for re-election | $210,000 | $199,996 | $0 | — | $0 | $409,996 |
| Laura LangIndependent · Talent and Compensation (Chair) · Audit | 112,500 | 199,996 | 0 | — | 0 | 312,496 |
| Vanessa A. WittmanIndependent · Audit (Chair) · Talent and Compensation | 112,500 | 199,996 | 0 | — | 0 | 312,496 |
| David PlouffeIndependent · Audit · Nominating and Corporate Governance | 85,000 | 199,996 | 0 | — | 0 | 284,996 |
| William Gassen IIIIndependent · Talent and Compensation · Nominating and Corporate Governance | 77,995 | 199,996 | 0 | — | 0 | 277,991 |
| Siddhartha SankaranIndependent | 70,000 | 199,996 | 0 | — | 0 | 269,996 |
| Elbert O. Robinson JrIndependent · Departed during FY | 33,001 | 0 | 0 | 0 | 0 | 33,001 |
Board fee structure and ownership guideline
| Annual cash retainer | $70,000 |
|---|---|
| Annual equity retainer | $200,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 35,000 / 32,500 / 15,000 |
| Stock ownership guideline | $5 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $700,996 |
| Equity awards (grant-date value) | $1,199,976 |
| All other compensation | $0 |
| Total cost of the board | $1,900,972 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Oscar Health as a peer
Companies that benchmark against OSCR
6 companies name OSCR as a compensation peer
- Alignment Healthcare, Inc.ALHCFY2025
- Astrana Health, Inc.ASTHFY2025
- Evolent Health, Inc.EVHFY2025
- Lemonade, Inc.LMNDFY2025
- Privia Health Group, Inc.PRVAFY2025
Each company listed discloses OSCR in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named OSCR in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
GDRX GoodRxCI Cigna GroupCNXC ConcentrixDVA DaVitaHQY HealthEquityLH LabcorpCNXC ConcentrixDVA DaVitaGDRX GoodRxHQY HealthEquityLH LabcorpCNC Centene CorporationCVS CVS Health CorporationHUM Humana Inc.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | GoodRx | 2025 | Wendy Barnes | $825,000 | $10,921,182 | $9,000,000 | $0 | $23,367,483 |
| 2 | Cigna Group | 2025 | David Cordani | 1,600,000 | 13,929,161 | 3,400,019 | 3,200,000 | 22,866,134 |
| 3 | CVS Health Corporation | 2025 | J. David Joyner | 1,500,000 | 14,499,931 | 0 | 4,695,900 | 21,214,084 |
| 4 | Centene Corporation | 2025 | Sarah London | 1,473,077 | 15,537,733 | 0 | 2,109,446 | 19,506,298 |
| 5 | Humana Inc. | 2025 | James Rechtin | 1,348,558 | 13,868,141 | 0 | 3,034,740 | 18,757,075 |
| 6 | Labcorp | 2025 | Adam Schechter | 1,435,000 | 11,400,463 | 2,754,582 | 2,062,095 | 18,339,913 |
| 7 | DaVita | 2025 | Javier Rodriguez | 1,500,000 | 11,442,481 | 2,699,982 | 2,089,491 | 18,210,597 |
| 8 | HealthEquity | 2026 | Scott Cutler | 775,000 | 12,038,563 | 0 | 767,250 | 13,582,105 |
| 9 | Concentrix | 2025 | Chris Caldwell | 852,603 | 10,531,825 | 0 | 1,757,025 | 13,347,449 |
| 10 | Oscar Health, Inc. | 2025 | Mark Bertolini | 619,178 | 0 | 0 | 169,036 | 1,149,308 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Oscar Health, Inc. | 91.0% | RSU 50 · PSU 50 | Yes — Relative TSR | FW Cook |
| Centene Corporation | 71.6% | PSU 60 · RSU 40 | Yes — Relative TSR | FW Cook |
| Cigna Group | 100% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| Concentrix | 82.2% | PSU 66 · RSU 34 | Yes — Total Shareholder Return (TSR) | FW Cook |
| CVS Health Corporation | 156.5% | PSU 60 · RSU 20 · Options 20 | Yes — rTSR Modifier | Korn Ferry |
| DaVita | 93% | PSU 60 · RSU 20 · Options 20 | Yes — Relative TSR v. S&P Health Care Services Select Industry Index | Compensia |
| GoodRx | not disclosed | not disclosed | not disclosed | Pay Governance |
| HealthEquity | 99% | PSU 60 · RSU 40 | Yes | Semler Brossy |
| Humana Inc. | 112% | PSU 60 · RSU 40 | Yes — Relative TSR | Farient Advisors, LLC |
| Labcorp | 95.8% | PSU 60 · RSU 20 · Options 20 | Yes — RELATIVE TSR MODIFIER | FW Cook |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-04 | 765,188,330 | 8,859,050 | 329,648 | 98.86% | Passed |
| 2025 | 2025-06-04 | 801,338,734 | 3,246,195 | 104,277 | 99.6% | Passed |
| 2024 | 2024-06-06 | 790,922,167 | 50,399,416 | 59,802 | 94.01% | Passed |
| 2023 | 2023-06-08 | 752,930,211 | 667,799 | 102,007 | 99.91% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-06-04 | 98.86%a |
| 2025 | 2025-06-04 | 99.6%b |
| 2024 | 2024-06-06 | 94.01%c |
a. Approved under the standard stated in the filing — “this means that the eight nominees receiving the highest number of affirmative "FOR" votes will be elected as directors Votes withheld and broker non-votes will have no effect Proposal 2: Advisory vote to approve named executive officer compensation ("Say-on-Pay") FOR The affirmative vote of the holders of a majority of the votes cast Abstentions and broker non-votes will have no effect Proposal 3: Ratification of appointment of PWC as our independent registered public accounting firm for 2026 Abstentions and broker non-votes, if any, will have no effect;”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes, if any, will have no effect.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 10.4 : 1 |
|---|---|
| CEO total compensation | $1,149,308 |
| Median employee compensation | $110,162 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Scott Blackley | Chief Financial Officer | 2026-05-14 | D | 8,741 | $24 | $207,948 | Common | Form 4 ↗ |
| Scott Blackley | Chief Financial Officer | 2026-05-14 | D | 91,259 | 23 | 2,108,083 | Common | Form 4 ↗ |
| Scott Blackley | Chief Financial Officer | 2026-05-18 | D | 110,000 | 25 | 2,753,300 | Common | Form 4 ↗ |
| Scott Blackley | Chief Financial Officer | 2026-06-02 | D | 8,977 | 22 | 201,534 | Common | Form 4 ↗ |
| Scott Blackley | Chief Financial Officer | 2026-06-02 | D | 22,706 | 22 | 493,628 | Common | Form 4 ↗ |
| Janet Liang | President, Oscar Insurance | 2026-06-02 | D | 3,535 | 22 | 79,361 | Common | Form 4 ↗ |
| Janet Liang | President, Oscar Insurance | 2026-06-02 | D | 8,940 | 22 | 194,356 | Common | Form 4 ↗ |
| Adam McAnaney | Chief Legal Officer | 2026-06-02 | D | 2,794 | 22 | 62,725 | Common | Form 4 ↗ |
| Adam McAnaney | Chief Legal Officer | 2026-06-02 | D | 7,065 | 22 | 153,593 | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-02 | D | 9,668 | 22 | 217,047 | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-02 | D | 24,452 | 22 | 531,586 | Common | Form 4 ↗ |
| Victoria Baltrus | Chief Accounting Officer | 2026-06-02 | D | 432 | 22 | 9,698 | Common | Form 4 ↗ |
| Victoria Baltrus | Chief Accounting Officer | 2026-06-02 | D | 1,091 | 22 | 23,718 | Common | Form 4 ↗ |
| Vanessa A. Wittman | Director | 2026-06-04 | A | 8,475 | 0 | 0 | Common | Form 4 ↗ |
| William Gassen III | Director | 2026-06-04 | A | 8,475 | 0 | 0 | Common | Form 4 ↗ |
| David Plouffe | Director | 2026-06-04 | A | 8,475 | 0 | 0 | Common | Form 4 ↗ |
| Laura Lang | Director | 2026-06-04 | A | 8,475 | 0 | 0 | Common | Form 4 ↗ |
| Siddhartha Sankaran | Director | 2026-06-04 | A | 8,475 | 0 | 0 | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 47,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | A | 660,000 | 10 | 6,435,000 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | A | 47,500 | — | — | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 50,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 660,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | A | 50,000 | — | — | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 880,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 97 | 30 | 2,919 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 31,912 | 30 | 943,957 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 15,491 | 29 | 448,464 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 102 | 30 | 3,069 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 33,592 | 30 | 993,651 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 16,306 | 29 | 472,059 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | A | 50,000 | — | — | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 102 | 30 | 3,069 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 33,591 | 30 | 993,622 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 16,307 | 29 | 472,088 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 1,799 | 30 | 54,132 | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 591,213 | 30 | 17,488,081 | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | D | 286,988 | 29 | 8,308,303 | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-06-23 | A | 880,000 | — | — | Common | Form 4 ↗ |
| Mark Bertolini | Director | 2026-06-25 | D | 17,200 | 29 | 500,176 | Common | Form 4 ↗ |
| Mark Bertolini | Director | 2026-06-25 | D | 597,942 | 29 | 17,101,141 | Common | Form 4 ↗ |
| Mark Bertolini | Director | 2026-06-26 | D | 149,795 | 30 | 4,462,393 | Common | Form 4 ↗ |
| Mark Bertolini | Director | 2026-06-26 | D | 441,373 | 29 | 12,848,368 | Common | Form 4 ↗ |
| Mark Bertolini | Director | 2026-06-29 | D | 58,926 | 30 | 1,772,494 | Common | Form 4 ↗ |
| Mark Bertolini | Director | 2026-06-29 | D | 555,826 | 29 | 16,213,444 | Common | Form 4 ↗ |
| Mark Bertolini | Director | 2026-06-30 | D | 135,590 | 29 | 3,928,042 | Common | Form 4 ↗ |
| Mark Bertolini | Director | 2026-06-30 | D | 488,654 | 28 | 13,853,341 | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-07-01 | D | 13,672 | 31 | 421,098 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-07-01 | D | 30,228 | 32 | 956,716 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-07-01 | D | 3,600 | 30 | 106,200 | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-07-01 | A | 47,500 | — | — | Common, indirect | Form 4 ↗ |
| Mario Schlosser | Director | 2026-07-01 | D | 47,500 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| William Gassen III | Director | 2026-07-09 | A | 684 | 31 | 21,341 | Derivative, Class A Common | Form 4 ↗ |
| Siddhartha Sankaran | Director | 2026-07-09 | A | 858 | 31 | 26,770 | Derivative, Class A Common | Form 4 ↗ |
| David Plouffe | Director | 2026-07-09 | A | 681 | 31 | 21,247 | Derivative, Class A Common | Form 4 ↗ |
| Scott Blackley | Chief Financial Officer | 2026-08-18 | D | 18,750 | 32 | 595,125 | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-08-27 | D | 600,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-08-27 | A | 600,000 | — | — | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-08-27 | A | 600,000 | 10 | 5,850,000 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-08-27 | D | 600,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-08-27 | D | 600,000 | 30 | 18,204,000 | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-08-28 | A | 150,000 | 10 | 1,462,500 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-08-28 | A | 150,000 | — | — | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-08-28 | D | 150,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-08-28 | D | 150,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-08-28 | D | 150,000 | 31 | 4,618,500 | Common | Form 4 ↗ |
| Adam McAnaney | Chief Legal Officer | 2026-09-03 | D | 9,092 | 31 | 285,943 | Common | Form 4 ↗ |
| Mario Schlosser | Director | 2026-09-03 | D | 31,422 | 31 | 988,222 | Common | Form 4 ↗ |
| Scott Blackley | Chief Financial Officer | 2026-09-03 | D | 28,869 | 31 | 907,930 | Common | Form 4 ↗ |
| Victoria Baltrus | Chief Accounting Officer | 2026-09-03 | D | 958 | 31 | 30,129 | Common | Form 4 ↗ |
| Janet Liang | President, Oscar Insurance | 2026-09-03 | D | 10,360 | 31 | 325,822 | Common | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | A | 75,520 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | D | 164,218 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | D | 4,855,810 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | D | 1,323,589 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | D | 164,218 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | D | 75,520 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | D | 164,218 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | D | 164,218 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | A | 164,218 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | A | 1,323,589 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | D | 75,520 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | A | 75,520 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Vanessa A. Wittman | Director | 2026-09-18 | D | 25,000 | 32 | 806,000 | Common | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | A | 6,268,097 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | D | 4,855,810 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | D | 1,323,589 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | A | 4,855,810 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | A | 1,323,589 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | D | 6,268,097 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | A | 6,268,097 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | D | 4,855,810 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | D | 1,323,589 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | D | 4,855,810 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | D | 1,323,589 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | A | 4,855,810 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Joshua Kushner | Director | 2026-09-18 | D | 6,268,097 | 0 | 0 | Common, indirect | Form 4 ↗ |
| Thrive Partners II GP, LLC | Director | 2026-09-18 | A | 164,218 | 0 | 0 | Common, indirect | Form 4 ↗ |
| William Gassen III | Director | 2026-10-08 | A | 698 | 33 | 23,104 | Derivative, Class A Common | Form 4 ↗ |
| Siddhartha Sankaran | Director | 2026-10-08 | A | 1,472 | 33 | 48,723 | Derivative, Class A Common | Form 4 ↗ |
| David Plouffe | Director | 2026-10-08 | A | 641 | 33 | 21,217 | Derivative, Class A Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (145 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Janet Liang. DEF 14A, filed 2026-04-22. Section “Executive Compensation Tables” · page 47. As printed: 10,400,673. View filing ↗
- Section 01, Mario Schlosser. DEF 14A, filed 2026-04-22. Section “Executive Compensation Tables” · page 47. As printed: 7,314,572. View filing ↗
- Section 01, Adam McAnaney. DEF 14A, filed 2026-04-22. Section “Executive Compensation Tables” · page 47. As printed: 7,129,097. View filing ↗
- Section 01, Scott Blackley. DEF 14A, filed 2026-04-22. Section “Executive Compensation Tables” · page 47. As printed: 4,752,808. View filing ↗
- Section 01, Mark Bertolini. DEF 14A, filed 2026-04-22. Section “Executive Compensation Tables” · page 47. As printed: 1,149,308. View filing ↗
- Section 03, Adam McAnaney PSU. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Adam McAnaney RSU. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Mario Schlosser PSU. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Mario Schlosser RSU. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Janet Liang OPTION. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Janet Liang RSU. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Janet Liang RSU. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Adam McAnaney RSU. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Adam McAnaney OPTION. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Janet Liang PSU. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Scott Blackley PSU. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Scott Blackley RSU. DEF 14A, filed 2026-04-22. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Scott Blackley RSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 03, Scott Blackley PSU. DEF 14A, filed 2026-04-22. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-22. Section “CEO Pay Ratio”. As printed: 10.4 : 1. View filing ↗
- Section 08, Jeffery H. Boyd. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 409,996. View filing ↗
- Section 08, Laura Lang. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 312,496. View filing ↗
- Section 08, Vanessa A. Wittman. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 312,496. View filing ↗
- Section 08, David Plouffe. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 284,996. View filing ↗
- Section 08, William Gassen III. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 277,991. View filing ↗
- Section 08, Siddhartha Sankaran. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 269,996. View filing ↗
- Section 08, Elbert O. Robinson Jr. DEF 14A, filed 2026-04-22. Section “Director Compensation”. As printed: 33,001. View filing ↗
- Section 02, Scott Blackley 2026-05-14. Form 4, filed 2026-05-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Blackley 2026-05-14. Form 4, filed 2026-05-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Blackley 2026-05-18. Form 4, filed 2026-05-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Blackley 2026-06-02. Form 4, filed 2026-06-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Blackley 2026-06-02. Form 4, filed 2026-06-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Janet Liang 2026-06-02. Form 4, filed 2026-06-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Janet Liang 2026-06-02. Form 4, filed 2026-06-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam McAnaney 2026-06-02. Form 4, filed 2026-06-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam McAnaney 2026-06-02. Form 4, filed 2026-06-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-02. Form 4, filed 2026-06-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-02. Form 4, filed 2026-06-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Victoria Baltrus 2026-06-02. Form 4, filed 2026-06-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Victoria Baltrus 2026-06-02. Form 4, filed 2026-06-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Vanessa A. Wittman 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, William Gassen III 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Plouffe 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Laura Lang 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Siddhartha Sankaran 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-06-23. Form 4, filed 2026-06-25. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Bertolini 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Bertolini 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Bertolini 2026-06-26. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Bertolini 2026-06-26. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Bertolini 2026-06-29. Form 4, filed 2026-07-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Bertolini 2026-06-29. Form 4, filed 2026-07-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Bertolini 2026-06-30. Form 4, filed 2026-07-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark Bertolini 2026-06-30. Form 4, filed 2026-07-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, William Gassen III 2026-07-09. Form 4, filed 2026-07-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Siddhartha Sankaran 2026-07-09. Form 4, filed 2026-07-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Plouffe 2026-07-09. Form 4, filed 2026-07-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Blackley 2026-08-18. Form 4, filed 2026-08-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-08-27. Form 4, filed 2026-08-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-08-27. Form 4, filed 2026-08-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-08-27. Form 4, filed 2026-08-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-08-27. Form 4, filed 2026-08-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-08-27. Form 4, filed 2026-08-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-08-28. Form 4, filed 2026-08-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-08-28. Form 4, filed 2026-08-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-08-28. Form 4, filed 2026-08-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-08-28. Form 4, filed 2026-08-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-08-28. Form 4, filed 2026-08-31. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Adam McAnaney 2026-09-03. Form 4, filed 2026-09-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mario Schlosser 2026-09-03. Form 4, filed 2026-09-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Scott Blackley 2026-09-03. Form 4, filed 2026-09-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Victoria Baltrus 2026-09-03. Form 4, filed 2026-09-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Janet Liang 2026-09-03. Form 4, filed 2026-09-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Vanessa A. Wittman 2026-09-18. Form 4, filed 2026-09-22. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joshua Kushner 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thrive Partners II GP, LLC 2026-09-18. Form 4, filed 2026-09-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, William Gassen III 2026-10-08. Form 4, filed 2026-10-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Siddhartha Sankaran 2026-10-08. Form 4, filed 2026-10-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Plouffe 2026-10-08. Form 4, filed 2026-10-13. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-06-09. Item 5.07 · say-on-pay result. As reported: 98.86% (votes for as printed: 765,188,330). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-06-06. Item 5.07 · say-on-pay result. As reported: 99.6% (votes for as printed: 801,338,734). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-06-11. Item 5.07 · say-on-pay result. As reported: 94.01% (votes for as printed: 790,922,167). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 700,996 + equity 1,199,976 + all other 0 = 1,900,972, summed across the director compensation table rows.
- GoodRx, Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in GoodRx's own proxy. As printed: 23,367,483. View filing ↗
- Cigna Group, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in Cigna Group's own proxy. As printed: 22,866,134. View filing ↗
- CVS Health Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in CVS Health Corporation's own proxy. As printed: 21,214,084. View filing ↗
- Centene Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-26. CEO total compensation as printed in Centene Corporation's own proxy. As printed: 19,506,298. View filing ↗
- Humana Inc., Section 10b CEO total. DEFR 14A, filed 2026-03-06. CEO total compensation as printed in Humana Inc.'s own proxy. As printed: 18,757,075. View filing ↗
- Labcorp, Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Labcorp's own proxy. As printed: 18,339,913. View filing ↗
- DaVita, Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in DaVita's own proxy. As printed: 18,210,597. View filing ↗
- HealthEquity, Section 10b CEO total. DEF 14A, filed 2026-05-13. CEO total compensation as printed in HealthEquity's own proxy. As printed: 13,582,105. View filing ↗
- Concentrix, Section 10b CEO total. DEF 14A, filed 2026-02-13. CEO total compensation as printed in Concentrix's own proxy. As printed: 13,347,449. View filing ↗
- Oscar Health, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Oscar Health, Inc.'s own proxy. As printed: 1,149,308. View filing ↗